2023年6月20日

全球药物研发外包市场规模预计将达到62亿美元,2030年预计将增长从2023年到2030年的复合年增长率为7.3%。COVID-19大流行带来了制药公司在聚光灯下。药物研发是一个昂贵而漫长的过程。这敦促制药和生物技术公司选择外包他们的研究活动,学术和私人合同研究组织(cro)需。公共或私人实体之间的关系上升加速药物发现过程,进而提高药物发现的全球外包服务需求。这种情况预计会维持post-Covid影响。例慢性病上升已敦促公司研发药物延长寿命。根据联合国,人们预计2015年和2020年之间的65岁生活17年。的一些关键治疗领域,公司正在积极参与外包包括肿瘤、心血管、抗感染。2020年11月,阿斯利康与9最重要的肿瘤医疗中心加快研究的一些hardest-to-treat癌症。 The company will be funding clinical and non-clinical research proposals from members of this network. The COVID-19 pandemic has demonstrated the value of drug discovery and development. People across the world are waiting for a vaccine while several companies are proactively involved in developing an effective vaccine to combat COVID-19. Pfizer Inc. and BioNTech SE received first approval for the vaccine following a worldwide Phase 3 trial of a potential strain to combat the virus. As for clinical trials, many of them are halted, while some are functional by adopting remote monitoring technologies. Thus, the pandemic has brought the pharmaceutical industry to center stage with drug discovery outsourcing becoming a key aspect to develop effective treatments against the virus. This is expected to boost the market revenue for the next 2 years i.e. a short-term boom, after which it shall regain its original growth curve. Companies Mentioned GenScript Drug Discovery Outsourcing Market Report Highlights In 2022, the lead identification & candidate optimization segment dominated the market. It is one of the most critical processes in drug discovery. Oncology and anti-infective are projected to be among the fastest-growing segments during the forecast period. Small molecules dominated the market in 2022. The segment is also projected to register a high CAGR during the forecast period. This, however, may change in the short term with higher emphasis on biologics. Asia Pacific is projected to be the fastest-growing regional market during the forecast period. The growth can be attributed to the government initiatives to forge alliances with U.S. pharmaceutical companies. Key Attributes: